FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Research on Assessing Terms Used in Drug Promotion

[ Price : $8.95]

Federal Register notice: FDA sends to OMB a proposed information collection entitled Assessment of Terms and Phrases Commonly Used...

Study on Medical Conference Drug Promoton

[ Price : $8.95]

Federal Register notice: FDA seeks comments on a proposed study entitled Medical Conference Attendees Observations About Prescript...

Survey on Drug Facility Risk Management

[ Price : $8.95]

Federal Register notice: FDA seeks comments on a proposed Survey of Drug Product Manufacturing, Processing and Packing Facilities ...

410 Medical Gains Expanded Use for LifeFlow

[ Price : $8.95]

FDA clears a 410 Medical 510(k) for its LifeFlow device for rapid delivery of blood and blood components, in addition to its previ...

FDA Makes Changes to Drug Name Program

[ Price : $8.95]

FDA makes modernized changes to its Phonetic and Orthographic Computer Analysis (POCA) program, the agencys software tool for dete...

House Panel Denounces Trump Block on Hahn Testimony

[ Price : $8.95]

House Energy and Commerce Committee leadership denounces the White House after it blocked FDA commissioner Stephen Hahn from testi...

Medimetriks Cutting Phase 3 Enrollment After FDA Meeting

[ Price : $8.95]

Medimetriks Pharmaceuticals says it received a Type C Meeting written response from FDA on MM36 (difamilast) for the topical treat...

Junshi Bio Orphan Status for Soft Tissue Sarcoma

[ Price : $8.95]

FDA grants Junshi Biosciences an orphan drug designation for toripalimab and its use in treating soft tissue sarcoma.

OPDP Looking at Medical Conference Drug Promotion

[ Price : $8.95]

The CDER Office of Prescription Drug Promotion says it wants to ask medical conference healthcare professional attendees about the...

FDA Publishes Covid-19 Molecular Test Comparisons

[ Price : $8.95]

FDA publishes a table comparing the performance of over 50 Covid-19 molecular diagnostic tests.